Skip to search formSkip to main contentSkip to account menu

dotatate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Lutathera (Lutetium Lu 177 Dotatate) First Radioactive Drug Approved for Gastroenteropancreatic Neuroendocrine Tumors
2017
2017
Pharmaceutical Approval Update.
Abuse-deterrent hydrocodone bitartrate (Vantrela ER) for long-term opioid treatment; etelcalcetide (Parsabiv) for secondary… 
2017
2017
Peptide Receptor Radionuclide Therapy & Oncology
markdownabstractNeuroendocrine tumors (NETs) are rare neoplasms with differences in clinical presentation, course and prognosis… 
2016
2016
177Hf as a Competitor in the Synthesis of 177Lu-DOTAtate
2015
2015
Clinical Study Kidney Dosimetry in 177 Lu and 90 Y Peptide Receptor Radionuclide Therapy : Influence of Image Timing , Time-Activity Integration Method , and Risk Factors
1 Medical Physics Department, European Institute of Oncology, 20141 Milan, Italy 2Medical Physics Department, IRCCS Arcispedale… 
2015
2015
177Lu Dotatate vs. sequential 177Lu Dotatate and 90Y Dotatate: treatment outcomes for PRRT patients at the Christie - a clinical audit.
2014
2014
Dosimetric measurements of 68Ga-High Affinity DOTATATE
Summary Purpose: 68Ga-labelled compounds are increasingly used for somatostatin-receptor scintigraphy because of their favourable… 
2014
2014
Dosimetrie von 68Ga-HA-DOTATATE
Purpose: 68Ga-labelled compounds are increasingly used for somatostatin-receptor scintigraphy because of their favourable… 
2013
2013
Cost-effective Ga-68 DOTATATE synthesis using shielded manual module
2002
2002
Biodistribution of yttrium and lutetium labeled DOTATOC and DOTATATE in rat tumor models.